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Intestinal anti-inﬂammatory eﬀects of artichoke
pectin and modiﬁed pectin fractions in the dextran
sulfate sodium model of mice colitis. Artiﬁcial
neural network modelling of inﬂammatory
markers†
Carlos Sabater,a Jose Alberto Molina-Tijeras,b Teresa Vezza,b Nieves Corzo,a
Antonia Montilla *a and Pilar Utrillab
Anti-inﬂammatory properties of artichoke pectin and modiﬁed fractions (arabinose- and galactose-free)
used at two doses (40 and 80 mg kg−1) in mice with colitis induced by dextran sulfate sodium have been
investigated. Expression of pro-inﬂammatory markers TNF-α and ICAM-I decreased in groups of mice
treated with original and arabinose-free artichoke pectin while IL-1β and IL-6 liberation was reduced only
in mice groups treated with original artichoke pectin. A decrease in iNOS and TLR-4 expression was
observed for most treatments. Intestinal barrier gene expression was also determined. MUC-1 and
Occludin increased in groups treated with original artichoke pectin while MUC-3 expression also
increased in arabinose-free pectin treatment. Galactose elimination led to a loss of pectin bioactivity.
Characteristic expression proﬁles were established for each treatment through artiﬁcial neural networks
showing high accuracy rates (≥90%). These results highlight the potential amelioration of inﬂammatory
bowel disease on mice model colitis through artichoke pectin administration.
1. Introduction
Pectin is widely used as a functional ingredient in the industry
due to its technological properties. However, in recent years,
its biological properties have gained attention.1 This complex
polysaccharide is mainly composed of a linear chain of galac-
turonic acid (GalA) units bonded by α(1,4) linkages called
homogalacturonan (HG), which comprises approximately 65%
of pectin and may be partially methyl-esterified at the O-6 carboxyl
and may be O-acetylated at O-2 or O-3. Other major domains
of pectin are rhamnogalacturonan-I (RG-I) and RG-II. RG-I
comprises 20–35% of the pectin structure and is made of
sequences of disaccharide [-4)-α-D-GalpA-(1,2)-α-L-Rhap-(1-]n.
Rhamnose (Rha) may be substituted at O-4 with linear or
branched oligosaccharides of arabinose (arabinans), galactose
(galactans) or both (arabinogalactans) showing degrees of poly-
merisation (DP) up to 47 units depending on the pectin
source.2 RG-II constitutes a minor and more complex domain
which comprises 10% of pectin. This domain consists of 12
diﬀerent types of sugars in over 20 diﬀerent linkages and is
largely conserved across plant species.3 Pectin technological
and biological properties are determined by its structural
characteristics such as the monomeric composition, molecular
weight (Mw), presence and distribution of side chains, degree
of methyl-esterification (DM, % methyl lesterification GalA) and
acetylation, and charge distribution along their backbone.4
Several studies evaluated the in vivo bioactivity of pectin
including its non-pharmacological administration to amelio-
rate the symptoms of inflammatory bowel disease (IBD).5,6
One of the most studied models for investigating the patho-
genesis of IBD is the dextran sulfate sodium (DSS)-induced
colitis mice model characterized by bloody faeces, diarrhoea,
weight loss and tissue inflammation. Expression of pro-inflam-
matory cytokines (IL-1β, TNF-α and IL-6) that may impair intes-
tine permeability and mucosal barrier function is also
increased, leading to intestine inflammation.7 It has been
reported that diets containing citrus pectin and probiotics
(Bifidobacterium longum) ameliorated the symptoms of acute
and chronic DSS-induced colitis in mice.8 Likewise, diets con-
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taining dietary pectin and inulin reduced intestinal inflam-
mation and cancer incidence in mice.9
Eﬀorts have been made to correlate pectin structural charac-
teristics with its anti-inflammatory eﬀect. Polysaccharides from
ginseng with high GalA, galactose and arabinose contents sup-
pressed pro-inflammatory cytokine expression in mice,10 and
soluble dietary fiber containing pectic substances, with high
GalA contents and DM, reduced gastric ulcer lesions in rats by
87%.11 Bioactivity of specific pectin domains or modified
pectin fractions has also been studied. For example, galacturo-
nan from starfruits showing high contents of arabinans and
arabinogalactans exerted antinociceptive and anti-inflamma-
tory properties in mice,12 and enzymatically modified apple
polysaccharides, using pectinases, may protect against colitis
associated colorectal cancer in mice.13 Moreover, it has been
demonstrated that arabinose and galactose contents may
determine the biological activity of pectin.14,15 In this sense,
pectin from artichoke by-products, because of its high content
of arabinose (127 mg g−1 of pectin) and galactose (24 mg g−1
of pectin),16 can be an interesting natural product to analyse
its anti-inflammatory properties.
On the other hand, data modelling allows discovering valu-
able information on complex chemical and biological events.
With this aim, machine learning algorithms like artificial
neural networks (ANN) have been recently applied to character-
ize artichoke pectin chains extracted by diﬀerent methods,17
and to determine complex structural patterns of pectic oligo-
saccharides obtained from diﬀerent pectin sources.18,19 In
addition, these advanced data analysis tools might be
employed to develop predictive models of disease course and
response to therapy, as well as for characterization of disease
heterogeneity and drug development for IBD.20
Therefore, the aim of this study was to investigate the anti-
inflammatory eﬀect of artichoke pectin (AP) and modified arti-
choke pectin fractions (without arabinose, APwA; or galactose,
APwG) in a experimental DSS model of colitis in mice. Then,
specific patterns in cytokine and intestinal protein expression
were established for each type of sample through ANN
modelling.
2. Materials and methods
2.1. Analytical standards and reagents
Analytical reference standards such as D-xylose, L-arabinose,
L-rhamnose, D-galactose, galacturonic acid (GalA) and phenyl-
β-glucoside were purchased from Sigma Aldrich (Steinheim,
Germany). Viscozyme®L (endo-1,3(4)-β-glucanase from Aspergillus
aculeatus) was a generous gift from Novozymes (Bagsvaerd,
Denmark). β-Galactosidase from Bacillus circulans and endo-
1,5-α-arabinanase from Aspergillus niger were acquired from
Biocon (Barcelona, Spain) and Megazyme (Bray, Ireland),
respectively. Citrus pectin (CP) was acquired from CEAMSA
(O’Porriño, Spain). DSS (36–50 kDa) was purchased from MP
Biomedicals (Santa Ana, CA, USA). RNAlater® was obtained
from Sigma Aldrich (Steinheim, Germany), and Tri-Reagent®
was acquired from Thermo Fisher Scientific (Invitrogen, USA).
The oligo (dT) primers (Promega, Southampton, UK) and
KAPA SYBRsFAST qPCR Master Mix (Kapa Biosystems, Inc.,
Wilmington, MA, USA) were used to perform the qPCR ana-
lyses. Ultrapure water (18.2 MΩ cm, with levels of 1–5 ng mL−1
total organic carbon and <0.001 EU mL−1 pyrogen) produced
in-house with a laboratory water purification system (Milli-Q
Synthesis A10, Millipore, Billerica, MA, USA) was used
throughout.
2.2. Obtainment and analysis of modified artichoke pectin
Artichoke pectin (AP) was previously extracted in our laboratory
using enzymatic preparation Celluclast®1.5L.16 Galactose-free
pectin (APwG) was obtained by enzymatic hydrolysis of 2%
(w/v) AP solutions dissolved in 0.05 M acetate buﬀer (pH 5.0)
with 0.7 U mL−1 of β-galactosidase from B. circulans at 50 °C
for 5 h. Similarly, arabinose-free pectin (APwA) was obtained
by enzymatic hydrolysis of 2% (w/v) AP solutions dissolved in
0.2 M acetate buﬀer (pH 4.0) with 0.4 U mL−1 of endo-1,5-
α-arabinanase from A. niger at 50 °C for 24 h. Samples were
immediately immersed in boiling water to inactivate the
enzyme. Then, modified pectins were purified using an
Ultracel® ultrafiltration (UF) membrane (Mw cut-oﬀ 1 kDa;
Millipore, Billerica, MA, USA). Retentates were freeze-dried for
subsequent analysis.
2.3. Analytical determinations
To determine the monomeric composition of purified APwG
and APwA, samples (2% w/v in 0.05 M sodium acetate buﬀer;
pH 5.0) were hydrolysed with 90 U mL−1 of Viscozyme®L
preparation and then sugars released were analysed as TMSO
by GC-FID, following the method previously described by
Sabater et al.16 On the other hand, complete Mw distribution
profiles of artichoke modified pectins were determined by
HPSEC-ELSD.16,18 The DM was determined by FT-IR.16,17 All
analyses were carried out in duplicate.
2.4. Experimental design
Potential anti-inflammatory properties in experimental colitis
mice of original AP, APwG and APwA were compared to those
of CP, which presents recognized anti-inflammatory activity.
This study was carried out in accordance with the Guide for
the Care and Use of Laboratory Animals as promulgated by the
National Institute of Health and the protocols were approved
by the Ethic Committee of Animal Experimentation of the
University of Granada (Spain) (Ref. No. CEEA 2010-286). Male
C57BL/6 mice (7–9 weeks old; 23 ± 2 g) were purchased from
Janvier (St Berthevin Cedex, France). Mice were housed in
Makrolon cages, maintained under an air-conditioned atmo-
sphere with a 12 h light–dark cycle, and provided free access to
tap water and a standard rodent diet (Panlab A04 diet, Panlab
S.A., Barcelona, Spain). Mice were maintained under specific
pathogen-free conditions in the facilities of the University of
Granada and were randomly assigned to ten groups of six animals
each (Table 1): (1) healthy, (2) DSS treated, (3) DSS treated
with: CP 40 mg kg−1, (4) CP 80 mg kg−1, (5) AP 40 mg kg−1,
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(6) AP 80 mg kg−1, (7) APwA 40 mg kg−1, (8) APwA 80 mg kg−1,
(9) APwG 40 mg kg−1, and (10) APwG 80 mg kg−1. Induction of
colitis was performed 15 days after the start of the experiment
by adding 3.0% (w/v) DSS to the drinking water for five days
(Table 1). Pectin fractions were diluted with water and admi-
nistered by oral gavage (100 μL per day) corresponding to
doses of 40 and 80 mg kg−1. Animal body weight, the presence
of gross blood in the faeces and the stool consistency were
registered to calculate the Disease Activity Index (DAI) (ESI
Table S1†). Once the animals were sacrificed, the colon was
aseptically removed and washed and then weighed. The ratio
between the colon weight and length was also considered as a
macroscopic indicator. Then, the expressions of pro-inflamma-
tory cytokines and barrier intestinal proteins were evaluated.
Total RNA from colonic samples was isolated, reverse tran-
scribed and amplified by qPCR using specific primers
(Table 2). mRNA expression was normalized using the house-
keeping gene, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) as the internal control. The mRNA relative was calcu-
lated using the ΔΔCt method.
2.5. Data analysis
ANOVA tests and Tukey’s test for p < 0.05 were applied to all
data generated. In order to establish reproducible patterns in
the expression of cytokines and intestinal proteins for each
group of mice treated with pectins, artificial neural network
(ANN) models were developed. ANNs are powerful pattern-reco-
gnition algorithms and the most common type of ANN is the
multilayer perceptron. This model is formed by an input layer
(i.e. biochemical markers), an output layer (i.e. treatment of
mice groups) and several neurons or nodes organised in
hidden layers, where each neuron in a layer is connected with
each neuron in the next layer through a weighted connection.
In addition, a mathematical transformation (activation func-
tion) is applied to the input layer to determine whether the
information that the neuron is receiving is relevant or not. Six
ANNs were computed to determine specific patterns for all
studied samples (both doses were included in the same
sample type group): (1) healthy control (ANN-1); (2) DSS
control (ANN-2); (3) CP (ANN-3); (4) AP (ANN-4); (5) APwA
(ANN-5); (6) APwG (ANN-6). Fig. 1 shows the architecture of
ANN used to determine patterns in pectin and modified pectin
treatments. The numbers of neurons in the hidden layer were
1, 5, 7, 50, 45 and 50 for ANN-1, -2, -3, -4, -5 and -6, respect-
ively. The number of neurons in the hidden layer depends on
the complexity of the input data (i.e. expression levels of bio-
chemical parameters). The number of neurons is one of the
most important parameters that need to be adjusted in an
ANN model to ensure its predictive power. This process is
called “parameter tuning”. One of the most common methods
Table 1 Experimental conditions used to study the eﬀect of consumption of artichoke pectin (AP), citrus pectin (CP) and modiﬁed artichoke pectin
fractions (APwA: modiﬁed artichoke pectin without arabinose and APwG: modiﬁed artichoke pectin without galactose) on mice treated with DSS
(3%, dextran sulfate sodium)
Mice groups (n = 6)
Animal weight
(kg)
Daily ingredient dose of treatment
(mg per kg of body weight)
DSS
supply (days)
Treatment
supply (days)
Healthy 0.023 ± 0.002 0 — —
DSS treated 0.022 ± 0.002 0 5 —
DSS treated + CP 40 0.023 ± 0.002 40 5 15
DSS treated + CP 80 0.023 ± 0.001 80 5 15
DSS treated + AP 40 0.023 ± 0.001 40 5 15
DSS treated + AP 80 0.023 ± 0.002 80 5 15
DSS treated + APwA 40 0.023 ± 0.002 40 5 15
DSS treated + APwA 80 0.023 ± 0.001 80 5 15
DSS treated + APwG 40 0.022 ± 0.002 40 5 15
DSS treated + APwG 80 0.023 ± 0.001 80 5 15
Table 2 Primer sequences used in real-time qPCR assays in colonic
tissue of diﬀerent groups of mice studied
Gene Sequence 5′-3′
Annealing T
(°C)
GAPDH FW 5′-CCATCACCATCTTCCAGGAG-3′ 60
RV 5′-CCTGCTTCACCACCTTCTTG-3′
TNF-α FW 5′-AACTAGTGGTGCCAGCCGAT-3′ 60
RV 5′-CTTCACAGAGCAATGACTCC-3′
IL-1β FW 5′-TGATGAGAATGACCTGTTCT-3′ 60
RV 5′-CTTCTTCAAAGATGAAGGAAA-3′
IL-6 FW 5′-TAGTCCTTCCTACCCCAATTTCC-3′ 60
RV 5′-TTGGTCCTTAGCCACTCCTTCC-3′
iNOS FW 5′-GTTGAAGACTGAGACTCTGG-3′ 67
RV 5′-ACTAGGCTACTCCGTGGA-3′
ICAM-1 FW 5′-CAGTCCGCTGTGCTTTGAGA-3′ 60
RV 5′-CGGAAACGAATACACGGTGAT-3′
TLR-4 FW 5′-GCCTTTCAGGGAATTAAGCTCC-3′ 60
RV 5′-AGATCAACCGATGGACGTGTAA-3′
MUC-1 FW 5′-GCAGTCCTCAGTGGCACCTC-3′ 60
RV 5′-CACCGTGGGCTACTGGAGAG-3′
MUC-2 FW 5′-GCTGACGAGTGGTTGGTGAAT-3′ 60
RV 5′-GATGAGGTGGCAGACAGGAGA-3′
MUC-3 FW 5′-CGTGGTCAACTGCGAGAATGG-3′ 60
RV 5′-CGGCTCTATCTCTACGCTCTCC-3′
Occludin FW 5′-ACGGACCCTGACCACTATGA-3′ 60
RV 5′-TCAGCAGCAGCCATGTACTC-3′
ZO-1 FW 5′-GGGGCCTACACTGATCAAGA-3′ 56
RV 5′-TGGAGATGAGGCTTCTGCTT-3′
TFF-3 FW 5′-CCTGGTTGCTGGGTCCTCTG-3′ 60
RV 5′-GCCACGGTTGTTACACTGCTC-3′
Villin FW 5′-CTCCGAGCAGATTGAGAAGG-3′ 60
RV 5′-GGTGCTGCCACTCTTCTACC-3′
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to find the optimal number of neurons for each model is
called “grid search”. In this method, a range of values for
each parameter that needs to be tuned is set (i.e. number of
neurons 1–100) and then, a model for every combination of
the parameter values is built. Once the performance of each
combination is evaluated, the optimal model is selected. The
activation function for ANN-1, -2 and -3 was logistic while
rectifier, tanh and maxout functions were used for ANN-4, -5
and -6, respectively. Variables were scaled and centered
before computing the analyses. All the models were trained
with 70% of the data, 10-fold cross-validated and then tested
with 30% of data from each class (corresponding to new
samples).
A variable importance analysis was carried out. The coeﬃ-
cients for each parameter (i.e. biochemical marker), were cal-
culated as the sum of the products of raw input-hidden and
hidden-output connection weights. These connection weights
are represented in Fig. 1 as lines connecting the input layer
(i.e. biochemical markers), the hidden layer (neurons) and the
output layer (i.e. type of treatment). Each biochemical marker
was expressed as the relative values, corresponding to variable
importance coeﬃcients divided by the highest variable impor-
tance value and multiplied by 100, so that values are bounded
between 0 and 100.
All statistical analyses were computed on R v3.5.0. ANN
models were built using RSNNS and H2O packages.
21,22
3. Results
3.1. Characterization of artichoke pectin and modified pectin
fractions
Characterization of CP and AP as well as modified artichoke
pectin fractions (APwG and APwA) purified by UF has been per-
formed in order to know structural diﬀerences and thus to
assess their influence on each group of mice studied.
Enzymatic treatment of AP with β-galactosidase from
B. circulans and endo-1,5-α-arabinanase from A. niger produced
galactose-free (APwG) and arabinose-free (APwA) modified arti-
choke pectin, respectively. Galactose release during enzymatic
hydrolysis was calculated considering the galactose contents of
initial AP (2.4 ± 0.0 mg 100 mg−1 dry matter of pectin) and
final of APwG (0.3 ± 0.0 mg 100 mg−1 dry matter of pectin)
leading to a loss of 87.5 ± 1.1% of total galactose present in
AP. Similarly, arabinose release during enzymatic hydrolysis
was calculated considering the arabinose contents of initial AP
(12.7 ± 0.6 mg 100 mg−1 dry matter of pectin) and final of
APwA (1.5 ± 0.2 mg 100 mg−1 dry matter of pectin) leading to a
loss of 88.2 ± 1.4% of total arabinose present in AP. The mono-
saccharide composition of AP, CP and modified pectins was
determined and expressed as percentages of total carbo-
hydrates (ESI Table S2†). Galactose content in APwG com-
prised 0.6% of total carbohydrates while arabinose content in
APwA comprised 1.4% of total carbohydrates. As expected,
Fig. 1 Artiﬁcial neural network (ANN) architecture used for determining biochemical patterns in mice groups treated with citrus pectin (CP; a) and
original artichoke pectin (AP; b), arabinose-free (APwA; c) and galactose-free (APwG; d) artichoke pectin. Weights are color-coded by sign (black+,
grey−) and thickness is in proportion to magnitude.
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modified artichoke pectins had a slightly higher GalA percen-
tage (76–77%) than the original pectin chain and APwA
showed significantly higher proportions of rhamnose (6.3%)
than AP (ESI Table S2†), highlighting that the linear backbone
of HG and RG-I was preserved. Xylose content was significantly
higher in APwG (1.5%). In contrast, commercial CP used as
the control showed significantly higher xylose and galactose
contents (2.5 and 11.1%) and lower arabinose contents than
AP. In addition, diﬀerent ratios (degree of branching (Rha/
GalA), linearity pectin backbone [GalA/(Rha + Ara + Gal)] and
extent of branching of RG-I [(Ara + Gal)/Rha]) were
calculated,16,17 showing primary structural properties of pectin
molecules, based on pectin monosaccharide composition data
(ESI Table S2†). Modified AP fractions showed a higher linear-
ity pectin backbone than original AP, although these diﬀer-
ences were not statistically significant. In contrast, APwA
showed a significantly lower extent of branching of RG-I than
APwG, indicating the removal of side chains during enzymatic
modification. These coeﬃcients between contents of GalA and
neutral pectic sugars indicate possible branching along the
pectin molecules.
Another important structural characteristic is DM, so CP
shows higher DM (71%) than AP (19.5%) and modified
pectins. On the other hand, APwG showed a multimodal Mw
distribution similar to original AP (ESI Table S3†) with three
main fragments of 605, 74 and 5.1 kDa. In contrast, APwA had
a bimodal distribution showing two main fragments of 542
and 63 kDa. It should be noted that CP used as the control
showed a monomodal distribution with one main fragment of
547 kDa.
3.2. Influence of pectin treatment on macroscopic indicators
of inflammatory bowel disease in DSS -treated mice
First, diﬀerent macroscopic indicators and symptoms of colitis
induced in mice by the oral administration of DSS were
studied. A significant weight loss was observed in all experi-
mental groups except for the healthy control group (Fig. 2a
and b). As expected, DSS-induced colitis produced a weight
loss in mice due to a systemic status of illness occasioned by
DSS as a general toxic. In general, weight losses in mice
treated with modified AP were similar to those of the DSS
control group. The only positive eﬀect was observed after the
administration of original AP at doses of 80 mg kg−1, resulting
in a lower weight reduction than CP with recognized anti-
inflammatory activity used as the control. In the AP 80 group,
no weight losses were observed at the seventh day of treatment.
Disease progression was monitored by calculating the DAI for
each group (Fig. 2c and d). AP at doses of 80 mg kg−1 resulted
in a significant decrease of the DAI value on the seventh and
eighth days compared to the sixth; these values were lower
than the one of CP at the same doses in agreement with high
weight loss values. No significant diﬀerences in the DAI com-
pared to the DSS control were observed for the rest of the
treatments.
On the other hand, the weight/length ratio of the colon was
determined (Fig. 3). This ratio reached its highest and lowest
values in DSS and healthy control groups, respectively. A stat-
istically significant decrease in this ratio (p < 0.05) with
respect to the DSS control group was only obtained for CP, AP
and APwG at doses of 80 mg kg−1. These results may highlight
a lower severity of inflammation and minor colonic cell infil-
tration in these groups (CP 80, AP 80 and APwG 80). These
results were in agreement with those of Pacheco et al.6 who
observed a significant reduction of IBD symptoms and
improvement of the animals’ general status in mice treated
with this CP. However, diﬀerences between the same product
administered at diﬀerent doses (40 and 80 mg kg−1) were not
statistically significant. In contrast, no significant diﬀerences
were found between the DSS group, the groups intake 40 mg
kg−1 dose of all ingredients and also APwA at 80 mg kg−1.
Considering this set of macroscopic indicators, an anti-
inflammatory eﬀect for original AP is shown leading to a sig-
nificant reduction of symptoms. However, enzymatic modifi-
cation of AP did not enhance its bioactivity.
3.3. Influence of pectin treatment on inflammatory
biochemical markers in DSS-treated mice corroborated by ANN
modelling
To gain deeper knowledge of the disease progression in mice,
several biochemical markers of IBD were assessed (Fig. 4 and
5). This set of markers consisted of several pro-inflammatory
parameters such as cytokines (TNF-α, IL-1β, IL-6), (Fig. 4)
enzymes (iNOS) and transmembrane receptors (ICAM-I, TLR-4;
Fig. 4); as well as diﬀerent epithelial integrity markers such as
barrier intestinal proteins (MUC-1, MUC-2, MUC-3, Occludin,
ZO-1, TFF-3, Villin) (Fig. 5). Given the great variability observed
between individuals, ANN models were trained on biochemical
parameters to obtain more robust and confident expression
patterns for each group of mice studied (healthy, DSS treated,
and DSS treated and supplemented with CP, AP, APwA and
APwG) which may help to interpret these results. These
models had diﬀerent architectures as it can be seen in Fig. 1.
The optimal number of neurons increases with input data
complexity. The ANN-1 model for the healthy control had only
1 hidden neuron because this group is the easiest to discrimi-
nate from the rest of the groups based on biochemical
markers, which were not altered. Similarly, the ANN-2 model
for DSS control is built with a small number of neurons
because this group shows the highest pro-inflammatory cyto-
kine levels and the lowest barrier protein expression values.
The ANN-3 model for CP control also had a small number of
neurons probably due to the accentuated eﬀect of CP on some
parameters like iNOS or Villin, so this type of pectin is easily
diﬀerentiated from the rest of the treatments. In contrast, AP
and modified AP fractions administered at both doses exerted
similar eﬀects on some of the biochemical parameters and it
was more diﬃcult to discriminate these treatments. The
expression profiles for these samples are more complex than
the ones observed for the controls and therefore, ANN models
with a larger number of neurons are needed.
These algorithms found a reproducible classification
pattern for each kind of substrate (ESI Table S4†), showing
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high prediction rates on the independent test set, above 90%
in all cases. Kappa, a more robust accuracy metric that con-
siders the possibility of a correct classification by chance,
showed the lowest values for APwA and original AP probably
due to the highest diﬀerences observed between the eﬀects of
these samples at the two studied doses (Fig. 4 and 5).
However, kappa values were above 0.80, indicating a high
reproducibility. Therefore, the ANN was able to find general
patterns that allow discriminating the biochemical profile
obtained for each group of mice studied considering these
Fig. 2 Macroscopic indicators weight gain (a and b) and disease activity index (DAI) (c and d) determined after sacriﬁce of mice groups: control
(healthy), DSS treated (dextran sulfate sodium) and DSS treated + diﬀerent types of pectins, citrus pectin (CP), and artichoke pectin (AP), modiﬁed
artichoke pectin without arabinose (APwA), and modiﬁed artichoke pectin without galactose (APwG). Mice were treated with two doses 40 and
80 mg kg−1.
Fig. 3 Weight/length ratio of the colon determined after sacriﬁce of mice groups: control (healthy), DSS treated (dextran sulfate sodium) and DSS
treated + diﬀerent types of pectins, citrus pectin (CP), and artichoke pectin (AP), modiﬁed artichoke pectin without arabinose (APwA), and modiﬁed
artichoke pectin without galactose (APwG). Mice were treated with two doses 40 and 80 mg kg−1. a,b,c,dStatistically signiﬁcant diﬀerences between
mice groups.
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high prediction rates, sensitivity, specificity and balanced
accuracy of these models (above 90%) (ESI Table S4†). To inter-
pret ANN results, the importance of each biochemical para-
meter in these models was calculated (Table 3). Diﬀerences
observed in cytokine expression profiles, based on this ana-
lysis, are discussed below.
As expected, DSS-induced colitic inflammation was charac-
terised by an altered immune response, which was evidenced
by an increasing mRNA expression of the pro-inflammatory
cytokines in comparison with non-colitic mice (Fig. 4). TNF-α
expression decreased in colitis mice treated with original or
modified pectin although this reduction was only statistically
significant (p < 0.05) in those groups treated with original AP
and APwA pectin at doses of 40 and 80 mg kg−1, respectively,
showing most similar values to those of the healthy group. No
significant diﬀerences were observed between APwG fractions
at both doses. ANN analysis corroborated these results; TNF-α
was one of the most relevant parameters in the profiles of
mice treated with APwA, showing a higher reduction compared
to other mice groups (Table 3). In addition, TNF-α was
especially relevant to discriminate the profiles of the DSS
control by ANN, indicating that this marker showed an accen-
tuated decrease in experimental mice groups treated with most
pectin samples. Similarly, IL-1β was significantly reduced
when AP was administered at 40 and 80 mg kg−1 while no sig-
nificant diﬀerences were observed among the rest of the
groups. IL-6 levels in CP and AP treatments at the two studied
doses (40 and 80 mg kg−1) were reduced, although diﬀerences
between groups were not statistically relevant due to the bio-
logical variability. It should be noted that APwA and APwG did
not reduce the expression of IL-6 at 40 mg kg−1, showing
similar values to those of the DSS group, indicating a loss of
potential immunostimulatory activity. IL-6 was also the most
relevant parameter in ANN profiles for the CP control, original
AP and APwG (Table 3). The ANN corroborates that CP and
original AP treatments reduced this pro-inflammatory cyto-
kine. In the case of APwG, analysis of variable importance indi-
cates that the negative results obtained for this type of pectin
did not exert any relevant eﬀect on IL-6 levels.
Remarkably, iNOS expression was significantly decreased in
all groups treated with AP and modified artichoke pectin frac-
tions at both doses, reaching expression levels similar to those
of the healthy group. ANN analysis revealed that iNOS was an
important parameter to discriminate the profiles of mice
treated with CP (Table 3) because this was the only treatment
that did not result in a reduction of iNOS levels. This fact may
be attributed to structural diﬀerences found between the two
pectins studied; thus CP presented a higher DM (71%) than
AP (19.5%) and modified artichoke pectins (24%) (ESI Table S2†).
Another pro-inflammatory marker determined was the
transmembrane receptor involved in the inflammatory process
ICAM-I (Fig. 4e), which was significantly reduced when AP and
APwA were administered at doses of 80 mg kg−1, reaching
values similar to those of the healthy control. ANN analysis
Fig. 4 Biochemical pro-inﬂammatory markers determined after sacriﬁce of mice groups: control (healthy), DSS treated (dextran sulfate sodium)
and DSS treated + diﬀerent types of pectins, citrus pectin (CP), and artichoke pectin (AP), modiﬁed artichoke pectin without arabinose (APwA), and
modiﬁed artichoke pectin without galactose (APwG); mice were treated with two doses 40 and 80 mg kg−1. a,b,cStatistically signiﬁcant diﬀerences
between mice groups.
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showed that ICAM-I was the most relevant marker to discrimi-
nate the biochemical profiles of DSS control groups because
all pectin and modified pectin treatments led to a decrease in
the levels of this parameter (Table 3). ICAM-I was also the
most important parameter in the profiles of mice treated with
APwA pectin as it was drastically reduced. Interestingly, ICAM-I
Fig. 5 Biochemical barrier intestinal proteins determined after sacriﬁce of mice groups: control (healthy), DSS treated (dextran sulfate sodium) and
DSS treated + diﬀerent types of pectins, citrus pectin (CP), and artichoke pectin (AP), modiﬁed artichoke pectin without arabinose (APwA), and
modiﬁed artichoke pectin without galactose (APwG); mice were treated with two doses 40 and 80 mg kg−1. a,b,cStatistically signiﬁcant diﬀerences
between mice groups.
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was relevant in APwG groups because this treatment led to a
lower reduction in the levels of ICAM-I compared to other
pectin samples.
A decrease in TLR-4 (Fig. 4f) expression was observed when
pectin or modified pectin was administered to mice groups
being significant under all conditions except for CP and APwA
treatments at 40 mg kg−1. ANN indicated that TLR-4 levels
diﬀerentiated the DSS control from the rest of the mice groups
(Table 3) and corroborated the overall anti-inflammatory eﬀect
in the expression of TLR-4 produced by all pectin and modi-
fied samples.
In general, a reduction of all pro-inflammatory markers is
produced, although the diﬀerences are not significant in
several cases. ANN models confirmed the potential activity of
AP and APwA fractions to modulate cytokine expression.
On the other hand, a group of anti-inflammatory markers
such as the expression of barrier intestinal proteins were
studied (Fig. 5). MUC-1 expression increased in those groups
treated with original AP. However, a great variability between
individuals was observed. ANN analysis showed that MUC-1
was an important factor in the profiles of original AP treated
groups (Table 3) as it produced a relevant increase in the levels
of this protein, showing the highest expression values.
In contrast, MUC-2 (Fig. 5b) levels were drastically low in all
studied groups with respect to the healthy control, showing
values similar to those of DSS control groups, so no positive
eﬀect on this marker was observed. Therefore, this was the
most relevant marker to discriminate the profiles of the
healthy mice group by ANN (Table 3). Similarly, the expression
of MUC-3 (Fig. 5c) for all tested groups was significantly lower
than that in the healthy group, with the exception of original
AP and APwA treatments at 80 and 40 mg kg−1, respectively.
With regard to other membrane proteins determined,
Occludin (Fig. 5d) levels were only significantly high in the
group treated with AP at 80 mg kg−1. ANN patterns indicated
that Occludin was a relevant parameter in the healthy mice
group and those mice groups treated with original AP
(Table 3), as no relevant increases were observed in the levels
of Occludin when other pectin samples were administered.
Moreover, this parameter was also relevant to discriminate
mice groups treated with APwG highlighting the absence of
any positive eﬀect; these groups showed the lowest expression
of this barrier protein compared to other pectin treatments.
In addition, no relevant diﬀerences were observed in TFF-3
levels (Fig. 5f) between diﬀerent pectin treatments due to the
high variability between individuals. The expressions of ZO-1
and Villin (Fig. 5e and g) were increased only for CP treatments
at 40 mg kg−1 and no significant diﬀerences were observed
between modified pectin fractions and original AP. These
results were corroborated by ANN analysis, revealing that Villin
was an important parameter in the healthy mice group and
mice treated with CP (Table 3). This fact indicates that treat-
ment of mice groups with CP was one of the most eﬀective
ones for reducing inflammatory cytokine IL-6 (as explained
above) leading to an increase in the expression of barrier
protein Villin. In contrast, ZO-1 was a relevant marker in the
biochemical profiles of mice treated with APwG.
As explained, some of these diﬀerences were not statistically
significant due to the high interindividual variability.
However, ANN modelling corroborates diﬀerences observed in
the obtained results and allows determining the most relevant
biochemical markers to be considered in each mice group.
Therefore, a dose-dependent response was observed for several
biochemical markers: pro-inflammatory TNF-α and IL-1β,
intestinal proteins and receptors MUC-1, Occludin and TLR-4.
AP was especially eﬃcient to reduce the expression of pro-
inflammatory cytokine IL-6 compared to other samples, while
APwA produced the most relevant eﬀect on the pro-inflamma-
tory receptor ICAM-I decrease. However, galactose-free modifi-
cation resulted in a loss of pro-inflammatory cytokine regu-
lation. In general, for APwG, the variable importance analysis
highlights the negative results obtained for this type of modi-
fied pectin, so the ANN model determined higher levels of
inflammatory markers ICAM-I and IL-6 and lower expression
Table 3 Variable importance analysis for all artiﬁcial neural network (ANN) model to study characteristic expression proﬁles of cytokine and intesti-
nal proteins in the diﬀerent groups of mice studied. DSS treated (dextran sulfate sodium), CP: citrus pectin control, AP: artichoke pectin, APwA:
modiﬁed artichoke pectin without arabinose, APwG: modiﬁed artichoke pectin without galactose
Parameter ANN-1 (healthy)
DSS treatment
ANN-2 (control) ANN-3 (+CP) ANN-4 (+AP) ANN-5 (+APwA) ANN-6 (+APwG)
TNF-α 3.8 34.0 46.3 69.3 96.1 81.8
IL-6 12.5 15.7 100 100 92.4 100
IL-1β 13.6 15.0 32.3 63.8 59.4 61.4
iNOS 5.4 3.6 80.8 63.1 82.9 77.4
ICAM-I 8.2 100 9.6 71.5 100 92.1
TLR-4 23.9 53.7 24.7 75.9 87.3 86.4
MUC-1 1.5 21.4 14.2 80.2 81.5 86.1
MUC-2 100 23.8 26.0 72.1 89.1 86.8
MUC-3 8.2 15.5 27.2 79.8 77.0 76.1
Occludin 43.9 7.7 32.0 86.2 82.9 91.0
ZO-1 33.1 4.9 25.0 75.6 91.8 87.9
TFF-3 41.0 27.6 25.6 74.1 76.1 76.6
Villin 63.2 22.4 64.6 74.3 71.5 77.0
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of intestinal barrier proteins Occludin and ZO-1 in the profiles
of these groups compared to the rest of the treatments.
Therefore, enzymatic modification with β-galactosidase from
B. circulans produced a significant loss of pectin bioactivity.
4. Discussion
The current work presents a study of the in vivo intestinal anti-
inflammatory eﬀect of AP and modified AP fractions in a DSS
model of mice colitis. The acute inflammatory response
involves high expression of macrophage-derived cytokine pro-
files with a high participation of TNF-α, IL-1β and iNOS as well
as adhesion molecule ICAM-I that enhances leukocyte endo-
thelial transmigration, leading to tissue damage.6 Several
studies reported in vitro and in vivo bioactivity of pectin and
pectic substances highlighting the importance of specific
structural features. One of the most relevant characteristics of
AP is the high presence of arabinose in its ramified domains
and low DM. According to previous studies, arabinose and
galactose contents exert an important influence on pectin anti-
inflammatory activity. Zhang et al.23 reported that pectic sub-
stances with high arabinose contents inhibit the production of
IL-6 and TNF-α in LPS-stimulated RAW264.7 cells while a
pectic polysaccharide from alfalfa, consisting mainly in the
RG-I domain of L-arabinosyl and D-galactosyl units, showed
potential inhibition of IL-1β and IL-6 gene expressions in the
same cell line.24 Arabinogalactan from edible jambo fruits
mainly composed of galactose and arabinose attenuated the
pro-inflammatory secretion induced by an inflammatory agent
in THP-1 cells,25 and silver linden flower pectins with RG-I
domains rich in arabinogalactans suppressed iNOS expression
and showed macrophage-stimulating activities,26 indicating
that neutral sugar content of pectin determines its anti-inflam-
matory activity. However, the higher influence of galactose
than arabinose was not reported in previous studies. In our
study, galactose content in AP proved to be especially relevant
to preserve pectin bioactivity (i.e. when galactose was removed
in APwG modified pectin, this product did exert little relevant
anti-inflammatory eﬀect) while APwA maintained an impor-
tant/significant pectin anti-inflammatory activity.
The DM also exerts a great influence on pectin bioactivity
according to previous in vitro studies. In this sense, in
THP-1 macrophages treated with highly methyl-esterified HG
branched by arabinogalactans and arabinans, TNF-α and IL1-β
secretion was reduced in the presence of a pro-inflammatory
agent.14 Similar in vitro immunostimulatory properties of
sweet pepper pectin were also preserved in modified fractions
obtained by acid hydrolysis where side chains had been
removed showing lower MW and DM.
27 In addition, laven-
der pectic polysaccharides containing a low-acetylated and
high-methoxylated HG domain and RG-I fragments rich in ara-
binan and arabinogalactan showed anti-inflammatory activity
on murine macrophages,28 and smaller pectic oligosaccharide
chains may also regulate anti-inflammatory cytokine secretion
(IL-1 receptor antagonist and IL-10) and may also inhibit the
activity of IL-1β.29 Selenylation of low methyl-esterified pectin
from Ulmus pumila L., containing galactan and glucan in its
side chains, inhibited nitric oxide production in RAW 264.7
cells resulting in a potential anti-inflammatory activity.30
These in vitro studies indicate that low methyl-esterified pectin
may exert anti-inflammatory activity, similar to high methyl-
esterified pectin or even higher. These results agree with our
study, where low methyl-esterified AP showed anti-inflamma-
tory potential, which was even higher than the one of high
methyl-esterified CP with recognised activity as the control.
Several studies reported in vivo anti-inflammatory pro-
perties of CP. Faecal microbiota transplantation combined
with pectin in DSS-induced colitis mice enhanced its posi-
tive eﬀects on the colonic ratio and DAI and reduced the
expression of TNF-α, IL-1β and IL-6.31 A reduction in
IL-1β, IL-6, and TNF-α in the murine model of endotoxin
shock has also been reported for CP treatment, as well as a
decrease in IL-6 secretion from Toll-like receptor-activated
RAW264.7 pretreated with CP. However, when this study was
performed using polygalacturonic acid, treatment was not
eﬀective, highlighting the importance of neutral sugars
present in side chains of pectin.32 Pacheco et al.6 studied the
expression of the inflammatory cytokine panel in the DSS-
model of mice colitis, which was reduced after the adminis-
tration of CP and orange by-products. These results agree with
our study where a similar reduction in pro-inflammatory cyto-
kine expression was observed for AP pectin and APwA, corro-
borating its immunostimulatory potential. It should be noted
that these two samples as well as CP used as the positive
control show high galactose contents.
AP samples evaluated in our study may interact with the
TLR-4 receptor leading to an overall decrease in the expression
of TNF-α, IL-1β and IL-6 biomarkers. This mechanism of
action was previously suggested by Liu et al.33 who evaluated
the protective eﬃcacy on intestinal toxicities and carcinogen-
esis of an apple oligogalactan by targeting the LPS/TLR-4/NF-
κB pathway in DSS-treated mice. These authors reported a
decrease in the expression of pro-inflammatory cytokines. On
the other hand, it has been demonstrated that TLR signalling
is suppressed by MUC-1,34 so AP enhances MUC-1 expression
leading to a decrease in TLR-4 levels and therefore, low
expression of pro-inflammatory cytokines IL-1, IL-6 and TNF-α.
This mechanism may explain some of the results obtained in
the present study.
Another interesting mechanism that may contribute to
interpretation of the anti-inflammatory eﬀects of AP is the
inhibition of carbohydrate-binding protein galectin-3. Previous
studies using CP found that low Mw modified fractions
reduced inflammation, fibrosis formation in organs and
tissues and cancer progression in a mouse model of colitis-
associated colon cancer by inhibiting galectin-3 to its ligand.
This process may induce apoptosis of cancerous cells.35,36 In
our study, AP modification did not enhance its bioactivity
although it should be noted that Mw distribution patterns of
APwG were similar to unmodified pectin. On the other hand,
an in vivo study of anti-inflammatory properties of apple
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pectin showed a decrease of TLR-4 and TNF-α levels in illeal
tissue of diet-induced obese rats,37 and apple pectin fractions
rich in galactose reduced tumour development in a mice
model of colitis-associated colon cancer through the inhibition
of galectin-3.36 These results agree with those of our study
where a significant reduction in galactose content present in
pectin chains led to a dramatic loss of its anti-inflammatory
activity, so galactose content of AP may be correlated with
pectin capacity to inhibit galectin-3.
In vivo studies dealing with alternative sources of pectin
found that RG-I fractions from potato pectin reduce the pro-
liferation of DLD1 and HCT116 colon cancer cells in a dose-
and time-dependent manner, as well as ICAM-I expression.
The presence of linear GalA segments as well as neutral sugar
side chains enhanced the bioactivity of these extracts.38
However, in our study it was found that higher linearity and
lower extent of branching of modified pectin fractions did not
result in an increase of their potential bioactivity, although
APwA (which showed higher linearity and lower extent of
branching as a consequence of enzymatic modification) pre-
served its anti-inflammatory properties. On the other hand,
noni fruit polysaccharides, containing RG-I regions with high
neutral sugar contents, such as arabinogalactans and arabi-
nans, reduced the DAI and promoted the expression of
mucosal and tight junction proteins like Occludin and ZO-1 in
DSS-induced IBD mice.5 Mzoughi et al.39 reported that a pectic
polysaccharide from Suaeda fruticosa, rich in arabinose and
galactose, exerted an anti-inflammatory eﬀect in rats at doses
of 100 mg per kg body weight. Modified pectic polysaccharides
from turmeric showing a high neutral sugar content, especially
galactose and rhamnose, and low Mw (13 kDa) reduced ulcer
in rats by decreasing pro-inflammatory factors like TNF-α and
galectin-3 levels.40 These studies indicate that a high neutral
sugar content and the degree of branching of pectin enhance
its anti-inflammatory potential.
However, in our study the galactose content of pectins (ESI
Table S2†) cannot explain diﬀerences observed between anti-
inflammatory eﬀects of CP and AP. These diﬀerences can also
be due to low DM of AP. As has previously been indicated, DM
of pectin is one crucial factor aﬀecting its anti-inflammatory
potential. Low methyl-esterified pectin from Opuntia micro-
dasys cladodes exerted an anti-inflammatory eﬀect in mice and
reduced gastric ulcer in rats at doses of 100 mg per kg body
weight.41 Similarly, low methyl-esterified pectic substances iso-
lated from common pondweed showed anti-endotoxemic
activity in mice by decreasing the expression of TNF-α and
IL-1β and increasing the levels of anti-inflammatory cytokines
such as IL-10.42 These studies agree with our results, where
low methyl-esterified AP showed a higher immunomodulatory
capacity than high methyl-esterified CP used as the control.
Considering the results obtained in our work, low methyl-
esterified pectins like AP may be proposed as good candidates
for their anti-inflammatory properties.
Immunostimulatory eﬀects in mice of both low and high
methyl-esterified CP have been compared, showing that low
methyl-esterified pectin decreased TNF-α release and increased
production of the anti-inflammatory cytokine IL-10 while high
methyl-esterified pectin had no eﬀect on cytokine pro-
duction.43 Sahasrabudhe et al.44 demonstrated that low
methyl-esterified pectin inhibits TLR-2 and specifically inhi-
bits the pro-inflammatory TLR-2–TLR-1 pathway by interacting
with TLR-2 through electrostatic forces between non-esterified
GalA and positive charges on the TLR-2 ectodomain. This
mechanism of action may explain diﬀerences observed
between high and low methyl-esterified pectins obtained in
our study, so AP may show a higher inhibition of Toll like
receptors pathways than CP due to its lower DM.
As explained, a great variability was observed in MUC-1 and
TLR-4 levels in those groups treated with modified AP.
Diﬀerences between groups were very subtle and biochemical
profiles were compared through ANN modelling indicating
that galactose content significantly contributes to pectin bioac-
tivity. Argüeso et al.15 found that modified citrus pectin
induces MUC-1. However, this positive eﬀect was reported to
be highly dependent on galactose content of pectin whereas
APwG yielded higher MUC-1 expression than APwA in our
study.
5. Conclusions
This work addresses the influence of structural characteristics
of artichoke pectin and modified pectin fractions on in vivo
anti-inflammatory activity. Original artichoke pectin gave rise
to a lower expression of pro-inflammatory cytokines in a dose-
dependent manner and a higher expression of some intestinal
barrier proteins. To establish characteristic expression profiles
of biochemical parameters for each type of treatment, ANN
models were developed. It has been demonstrated that DM
exerts a great influence together with pectin neutral sugar
content, degree of branching and Mw. With regard to pectin
monomeric composition, it has been observed that galactose
content is especially relevant to preserve pectin anti-inflamma-
tory properties while arabinose removal does not result in a
drastic loss of bioactivity. Further studies are needed to com-
pletely elucidate the complex mechanism of action of pectin,
based on its structural features. Taking into account these
results, AP can be used as a functional ingredient that may be
extracted from artichoke industrial by-products as novel pectin
source.
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